Danuglipron is an oral, non-peptide GLP-1 receptor agonist with a pharmacological mechanism that predominantly activates the G protein rather than -arrestin
Long-term studies involving elderly subjects demonstrated improvements in immune system indices alongside cardiovascular, endocrine, and nervous system function
However, there are zero scientific studies supporting use of ALC in weight loss that I could find
Heptulla RA, Rodriguez LM, Mason KJ, Haymond MW
The prime motivator for PA has been cost
The STEP trials further highlight its exceptional effectiveness in weight control, with participants achieving up to 20% weight loss alongside improvements in obesity-related comorbidities